FDA Commissioner Drops Bomb on Fauci: Myocarditis Cover-Up Exposed [WATCH]

FDA Commissioner Marty Makary discussed concerns over past public health decisions, vaccine data transparency, and federal research spending during an exchange with commentator Benny Johnson, touching on issues ranging from COVID-19 vaccine side effects to National Institutes of Health funding priorities.

Johnson raised questions about actions taken by federal officials during the COVID-19 pandemic, referencing a criminal referral made by Sen. Rand Paul related to former National Institute of Allergy and Infectious Diseases director Dr. Anthony Fauci.

Johnson asked whether Makary believed there had been misconduct within federal agencies during prior administrations.

Here’s What They’re Not Telling You About Your Retirement

“We have Senator Rand Paul on all the time, Mr. Commissioner, and he’s constantly banging on about his criminal referral for Dr. Fauci. In your time at the FDA, have you, do you believe that there’s perhaps criminal influence that may have happened in different eras?” Johnson said.

Makary responded by stating that the FDA does not maintain direct records of Fauci’s activities while he was at the NIH, but pointed to issues involving how certain vaccine-related data had been handled.

He cited myocarditis, an inflammation of the heart muscle, as a complication associated with COVID-19 vaccines, particularly in younger populations.

“Well, Dr. Fauci, since he was at the NIH we don’t directly have any records of his activities, but we did see a cover up to silence data on myocarditis, a covid vaccine complication, highest in young kids. So young kids were the lowest risk for covid, getting in trouble with covid infection, and they were the highest risk for myocarditis. So by sort of suppressing that information, it sort of created misrepresentation the risk benefit ratio,” Makary said. Dr. Fauci, since he was at the NIH, we don’t directly have any records of his activities, but we did see a cover-up

This Could Be the Most Important Video Gun Owners Watch All Year

Makary added that information about myocarditis has since been made public and is now included in vaccine labeling, stating that current efforts are focused on clarifying the record.

“Now that data has since been made public, and myocarditis appears in the label of these vaccines. So we’re doing what we can to set the record straight,” Makary said.

He also described broader concerns about federal research funding and agency priorities when the current administration took office, referencing past allocations of NIH grant funding and international research efforts.

“But look, when we came to office, we walked into a mess. We had been funding a lab in Wuhan China that likely brewed up the virus that killed 25 million people. We walked into 12% to 14% of NIH grants were going to DEI not to curing rare diseases or cancer or or kidney disease or diabetes, but to describing differences in the population, which they we already know are are true,” Makary said.

Makary said the administration has sought to shift focus toward health issues affecting children, particularly chronic disease, and to implement policy changes tied to federal nutrition programs.

“So we walked into a mess. And so what we wanted to see was money go towards important things that have to do with the well being of kids, addressing the 40% of American kids that have a chronic disease having snap waivers for the first time in government, where Brooke Rollins has said now, 20 states have applied for these SNAP waivers where you don’t have to use taxpayer dollars for junk food in the SNAP program,” Makary said.

He added that the administration is willing to pursue significant changes in policy as part of its approach to public health and federal spending.

“So we’re not afraid to go radical. And that’s exactly where we’re going,” Makary said.

WATCH:

Warning: Account balances and purchasing power no longer tell the same story. Know in 2 minutes if your retirement is working for you.